MEASURE WILL PROTECT DISTRICT RESIDENTS FROM UNETHICAL PRESCRIPTION DRUG MARKETING TACTICS

Washington, D.C.  – Today, the D.C. Council’s Committee of the Whole placed the “SafeRx Act of 2007” on the agenda of the Council’s next Legislative Meeting on December 11, 2007.  The measure will protect District of Columbia residents from several potentially harmful prescription drug marketing practices. Among other things, the legislation will require the licensure of pharmaceutical representatives and prohibit them from providing knowingly false information to physicians.

“I look forward to bringing this important legislation to a vote,” said Catania.  “I expect that the pharmaceutical industry will lobby my colleagues intensely over the next couple weeks.  However, I am confident that the Council will put the health and safety of our residents before the profits of pharmaceutical companies.”

Full Press Release